Autres langues Surmodics, Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 31/05/2024			Varia. 5j.	Varia. 1 janv.
42,06 ^USD	-0,10 %		+22,34 %	+15,71 %

30/05	SURMODICS, INC. : Barrington Research neutre sur le dossier	ZM
29/05	SURMODICS, INC. : Needham & Co. neutre sur le dossier	ZM

SURMODICS, INC. : Barrington Research neutre sur le dossier	30/05
SURMODICS, INC. : Needham & Co. neutre sur le dossier	29/05
Sector Update: Health Care Stocks Lean Lower Premarket Wednesday	29/05
Sector Update: Health Care	29/05
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday After Fed Speaker's Hawkish Comments	29/05
Top Premarket Gainers	29/05
SurModics Agrees to be Acquired by Private Equity Firm GTCR for $627 Million; Shares Rise Pre-Bell	29/05
SURMODICS, INC. : Barrington Research reste à l'achat	02/05
Top Midday Gainers	01/05
Transcript : Surmodics, Inc., Q2 2024 Earnings Call, May 01, 2024	01/05
Surmodics, Inc. Revises Earnings Guidance for the Fiscal Year 2024	01/05
Surmodics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	01/05
SURMODICS, INC. : Barrington Research maintient sa recommandation à l'achat	06/02
SURMODICS, INC. : Needham & Co. à l'achat	01/02
Surmodics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	01/02
Transcript : Surmodics, Inc., Q1 2024 Earnings Call, Feb 01, 2024	01/02
Surmodics, Inc. Provides Earnings Guidance for the Fiscal Year 2024	01/02
Surmodics, Inc. Announces Successful Early Clinical Use of its Pounce LP Thrombectomy System	22/01
Surmodics, Inc. Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium	16/11
Surmodics, Inc. Announces 24-Month Data from the Swing Trial Presented At VEITHsymposium	16/11

Aucun résultat pour cette recherche